Visits: 2486, Avg visit time (secs): 232,77 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 889 | 35,76% | |
| /msd/albert-renold/efsd-msd-arenold.html | 309 | 12,43% |
| /programmes.html | 256 | 10,30% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 225 | 9,05% |
| /lilly/fellowships/efsd-lilly-fship09.html | 188 | 7,56% |
| /novo-t2/efsd-novo-t2-rfa09.html | 47 | 1,89% |
| /pfizer/efsd-pfizer-rfa09.html | 46 | 1,85% |
| /new_horizons/new-horizons09.html | 32 | 1,29% |
| /amylin/efsd-amylin-rfa09.html | 31 | 1,25% |
| /novartis/efsd-novartis-rfa09.html | 31 | 1,25% |
| /home.html | 26 | 1,05% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 983 | 39,54% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 249 | 10,02% |
| /msd/albert-renold/efsd-msd-arenold.html | 197 | 7,92% |
| /lilly/fellowships/efsd-lilly-fship09.html | 133 | 5,35% |
| /lilly/programme/efsd-lilly-cds-fellowship08.htm | 84 | 3,38% |
| /programmes.html | 67 | 2,70% |
| /lilly/programme/efsd-lilly-rfa09.html | 61 | 2,45% |
| /gsk/efsd-gsk-rfa08.html | 57 | 2,29% |
| /home.html | 52 | 2,09% |
| /lilly/programme/efsd-lilly-cds-fellowship09.html | 47 | 1,89% |
| /pfizer/efsd-pfizer-rfa09.html | 46 | 1,85% |